Medications

Drug OK'd for deadly genetic condition tied to cholesterol

(HealthDay)—Kynamro (mipomersen sodium) has been approved by the U.S. Food and Drug Administration to treat a rare inherited condition in which the body can't remove low-density lipoprotein (LDL) cholesterol from the blood.

Diabetes

In STEMI, diabetes linked to worse long-term outcomes

(HealthDay)—In patients undergoing primary angioplasty for ST-segment elevation myocardial infarction (STEMI), diabetes is associated with worse long-term outcomes, including mortality, reinfarction, stent thrombosis, and ...

Medications

FDA approves juxtapid for rare cholesterol disorder

(HealthDay)—The U.S. Food and Drug Administration has approved the orphan drug Juxtapid (lomitapide) for patients with homozygous familial hypercholesterolemia (HoFH), for use in combination with a low-fat diet and other ...

Medical research

Greater drop in LDL seen with atorvastatin plus PCSK9 antibody

(HealthDay)—Addition of the fully human serum proprotein convertase subtilisin/kexin 9 monoclonal antibody, SAR236553, to atorvastatin is associated with greater reductions in low-density lipoprotein (LDL) cholesterol levels ...

Cardiology

Smoke-free workplace laws lead to decline in MI incidence

(HealthDay)—Following implementation of workplace smoke-free laws, the incidence of myocardial infarction (MI) decreased significantly in Olmsted County, Minn., according to a study published online Oct. 29 in the Archives ...

Overweight & Obesity

Psyllium reduces metabolic syndrome risk factors

(HealthDay) -- Consumption of the fiber supplement psyllium correlates with reductions in risk factors for metabolic syndrome, according to a study published online Aug. 5 in Obesity Reviews.

page 5 from 7